Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
22/09/2025
Snap Inc.'s stock price touched a seven-week high, rising 10.9% most recently.
Latest
2 m ago
TATA Health (01255.HK) releases mid-year performance report for 2024, with a net loss attributable to shareholders of 5.13 million Hong Kong dollars, a 58.38% decrease compared to the same period last year.
3 m ago
Market news: Iraq and oil companies are preparing to sign an agreement to restart exports from the Kurdish region.
3 m ago
Pfizer Inc. rose 2.1% in early trading. It is reported that Pfizer Inc. is set to acquire weight loss drug manufacturer Metsera for $7.3 billion. The deal values Metsera at $47.50 per share, with an additional $22.50 linked to performance milestones, representing a 42.5% premium to its latest closing price. This acquisition aligns with Pfizer's strategy to expand its product portfolio in the growing weight loss drug market.
3 m ago
Pfizer (PFE) rose 21.1% in early trading. It is reported that Pfizer is set to acquire weight loss drug manufacturer Metsera (MTSR) for $7.3 billion. The deal values Metsera at $47.50 per share, with an additional $22.50 linked to performance milestones, representing a 42.5% premium to its latest closing price. This acquisition aligns with Pfizer's strategic goal of expanding its product portfolio in the growing weight loss drug market.
3 m ago
The stock price of GameStop has reached a three and a half month high, rising 4.4% most recently.
See all latest
